We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

70 hedge funds and large institutions have $16.7M invested in Spectrum Pharmaceuticals Inc in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

245% more call options, than puts

Call options by funds: $276K | Put options by funds: $80K

7% less funds holding

Funds holding: 75 → 70 (-5)

26% less capital invested

Capital invested by funds: $22.7M → $16.7M (-$5.98M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

44% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 25

Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
25
Closed
13
Calls
$276K
Puts
$80K
Net Calls
+$196K
Net Calls Change
+$76K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.01M
2
AC
Armistice Capital
New York
+$137K
3
Citadel Advisors
Citadel Advisors
Florida
+$125K
4
Jane Street
Jane Street
New York
+$76.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$29.1K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.41M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.17M
3
Bank of America
Bank of America
North Carolina
-$272K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$255K
5
GCP
GSA Capital Partners
United Kingdom
-$244K
Name Holding Trade Value Shares
Change 		Change in
Stake
FIA
51
Foundations Investment Advisors
Arizona
$3.69K +$4.22K +10,000 New
Fidelity Investments
52
Fidelity Investments
Massachusetts
$1.96K +$1.9K +4,495 +542%
UBS Group
53
UBS Group
Switzerland
$1.37K +$636 +1,508 +69%
KFI
54
Key Financial Inc
Pennsylvania
$1.07K – – –
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$1.03K +$638 +1,513 +117%
JP Morgan Chase
56
JP Morgan Chase
New York
$1K -$3.3K -7,821 -67%
PVH
57
Psagot Value Holdings
Israel
$1K – – –
SPIA
58
Steward Partners Investment Advisory
New York
$829 – – –
FDCDDQ
59
Federation des caisses Desjardins du Quebec
Quebec, Canada
$590 – – –
DFCM
60
Dark Forest Capital Management
Puerto Rico
$486 +$557 +1,320 New
AF
61
Allworth Financial
California
$439 +$502 +1,190 New
FWM
62
Focused Wealth Management
New York
$295 – – –
Dimensional Fund Advisors
63
Dimensional Fund Advisors
Texas
$162 – – –
TWA
64
TCI Wealth Advisors
Arizona
$37 +$42 +100 New
CA
65
CoreCap Advisors
Michigan
$9 +$10 +24 New
IAA
66
Independent Advisor Alliance
North Carolina
$4 – – –
Jacobs Levy Equity Management
67
Jacobs Levy Equity Management
New Jersey
– -$255K -594,108 Closed
CCM
68
CAAS Capital Management
New York
– -$123K -285,441 Closed
LP
69
LMR Partners
United Kingdom
– -$33K -77,541 Closed
ZIM
70
Zacks Investment Management
Illinois
– -$17K -40,256 Closed
DMKJ
71
David M. Knott Jr
– -$16K -36,900 Closed
Man Group
72
Man Group
United Kingdom
– -$15K -34,208 Closed
Wolverine Trading
73
Wolverine Trading
Illinois
– -$9.53K -22,599 Closed
UAS
74
United Asset Strategies
New York
– -$8K -18,000 Closed
ProShare Advisors
75
ProShare Advisors
Maryland
– -$7K -15,826 Closed
1 2
3
4

SPPI Hedge Fund Activity: Q4 2022 in Review

70 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2022, worth a combined $16.7M — down 26% from $22.7M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SPPI and 8 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 14 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.01M. The largest seller was BlackRock, cutting an estimated $1.41M.

  • 70 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2022, down from 75 in Q3 2022.
  • Funds reported $16.7M of Spectrum Pharmaceuticals Inc stock for Q4 2022, down 26% quarter-over-quarter.
  • 8 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2022 and 13 closed out, a net change of -5 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2022 was Acadian Asset Management, an estimated $1.01M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2022 was BlackRock, an estimated $1.41M sold.

Based on aggregated 13F filings for Q4 2022.